parallax background

There was a lot of excitement around our Shire-focused session in Boston … and the panel did not disappoint. Highlights from the conversation are condensed in these two new articles on our parent publication, OutsourcedPharma.com.

 

Creating Shire’s Outsourcing Model

$7 billion in annual sales and fully reliant on outsourcing … How does it all fit together? How is it managed?

Read the article.

Mani Sundararajan, VP & Head Global Pharmaceutical Technology at Shire, discusses the Shire approach to outsourcing.
 
Charlene Banard, SVP Quality at Shire, discusses M&A strategy at the outsourcing giant.
 

Shire's Approach to CMOs & M&As

On being the quintessential “acquisitive company” … how a 3-pronged strategy for CMO integration makes it all work.

Check out the story.

Many thanks to our friends at Shire for putting together this top-notch session:
Mani Sundararajan (VP & Head Global Pharma Technology), Srini Tenjarla (Head Global Pharma Sciences), Charlene Banard (SVP Quality)